Mimedx (MDXG) Asset Writedowns and Impairment (2016 - 2026)

Mimedx has disclosed Asset Writedowns and Impairment across 10 years of filings, most recently posting $1.5 million for Q1 2026.

• Asset Writedowns and Impairment for Q1 2026 came in at $1.5 million, up 97.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.2 million (up 536.5% YoY), and the FY2025 annual result was $6.5 million, up 994.96% from the prior year.
• Asset Writedowns and Impairment came in at $1.5 million for Q1 2026 at Mimedx, down from $3.4 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $3.4 million in Q4 2025 to a low of -$279000.0 in Q3 2024.
• The 5-year median for Asset Writedowns and Impairment is $436500.0 (2022), against an average of $834687.5.
• Across the five-year window, Asset Writedowns and Impairment soared 48200.0% in 2023 and tumbled 162.42% in 2024, its largest moves.
• Mimedx's Asset Writedowns and Impairment stood at $3000.0 in 2022, then jumped by 48200.0% to $1.4 million in 2023, then sank by 68.67% to $454000.0 in 2024, then jumped by 641.41% to $3.4 million in 2025, then tumbled by 56.51% to $1.5 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at $1.5 million (Q1 2026), $3.4 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.